![Michaela Ott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michaela Ott
Direttore/Membro del Consiglio presso Medite Enterprise, Inc.
Posizioni attive di Michaela Ott
Società | Posizione | Inizio | Fine |
---|---|---|---|
Medite Enterprise, Inc.
![]() Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Direttore/Membro del Consiglio | 01/01/2013 | - |
Storia della carriera di Michaela Ott
Precedenti posizioni note di Michaela Ott
Società | Posizione | Inizio | Fine |
---|---|---|---|
MEDITE CANCER DIAGNOSTICS INC | Direttore/Membro del Consiglio | 03/04/2014 | 17/01/2018 |
Amministratore Delegato | 03/04/2014 | 26/10/2016 | |
Direttore operativo | 26/10/2016 | 04/05/2017 | |
Medite GmbH /Austria/
![]() Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Amministratore Delegato | - | 30/09/2017 |
MEDITE GmbH
![]() MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Presidente | 01/01/2006 | 04/05/2017 |
CytoCore, Inc.
![]() CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Amministratore Delegato | 03/04/2014 | - |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Germania | 2 |
Austria | 2 |
Posizioni
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 1 |
Settori
Health Technology | 5 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDITE CANCER DIAGNOSTICS INC | Health Technology |
Aziende private | 4 |
---|---|
CytoCore, Inc.
![]() CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
MEDITE GmbH
![]() MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Distribution Services |
Medite Enterprise, Inc.
![]() Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Health Technology |
Medite GmbH /Austria/
![]() Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Health Technology |
- Borsa valori
- Insiders
- Michaela Ott
- Esperienza